APA (7th ed.) Citation

Nishikawa, H., Ohnishi, S., Hayashi, H., Okamoto, R., Yamahara, K., Isoe, T., . . . Fujimori, Y. Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: A study protocol for a phase I/II Japanese trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Nishikawa, Hiroki, et al. Safety and Efficacy of Amnion-derived Mesenchymal Stem Cells (AM01) in Patients with Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Haematopoietic Stem Cell Transplantation: A Study Protocol for a Phase I/II Japanese Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Nishikawa, Hiroki, et al. Safety and Efficacy of Amnion-derived Mesenchymal Stem Cells (AM01) in Patients with Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Haematopoietic Stem Cell Transplantation: A Study Protocol for a Phase I/II Japanese Trial. BMJ Publishing Group.